Acrivon Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRV and other ETFs, options, and stocks.

About ACRV

Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). 

CEO
Peter Blume-Jensen
CEOPeter Blume-Jensen
Employees
78
Employees78
Headquarters
Watertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded
2018
Founded2018
Employees
78
Employees78

ACRV Key Statistics

Market cap
39.35M
Market cap39.35M
Price-Earnings ratio
-0.55
Price-Earnings ratio-0.55
Dividend yield
Dividend yield
Average volume
687.85K
Average volume687.85K
High today
$1.27
High today$1.27
Low today
$1.22
Low today$1.22
Open price
$1.24
Open price$1.24
Volume
538.26K
Volume538.26K
52 Week high
$10.16
52 Week high$10.16
52 Week low
$1.05
52 Week low$1.05

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own ACRV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.